FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2775871907> ?p ?o ?g. }

• W2775871907 endingPage "387" @default.
• W2775871907 startingPage "380" @default.
• W2775871907 abstract "Summary Objective Glucocorticoids ( GC s) are the first‐line treatment for myasthenia gravis ( MG ) and act as long‐term immunosuppressants. However, GC s can induce osteoporosis and bone fractures. In this study, we evaluate the effects of oral alendronate and alfacalcidol, or alfacalcidol alone on the bone of Chinese patients with MG who will initiate treatment with GC s. Design and methods A total of 75 patients were included in this 12‐month prospective, open‐label, single‐centre study. Patients with bone mineral density ( BMD ) T‐score less than −1.0 at baseline were treated with 70 mg of alendronate per week. Patients with BMD T‐score greater than −1.0 at baseline were included in the alfacalcidol‐alone group. Patients in two groups were treated with 0.25 μg of alfacalcidol every other day and 600 mg of calcium daily. Results After 12 months of treatment, the mean BMD of lumbar spine, femoral neck and total hip increased by 3.4% ( P = .002), 1.8% ( P = .21) and 2.6% ( P = .02), respectively, in alendronate group. In alfacalcidol‐alone group, the mean BMD of lumbar spine, femoral neck and total hip decreased by 6.1%, 3.2% and 3.3%, respectively (all P < .001 vs baseline). Conclusions We demonstrated for the first time that treatment with alendronate combined with alfacalcidol significantly increased BMD , decreased bone turnover biomarker levels and reduced the occurrence of hypercalciuria in a large cohort of Chinese patients with MG who initiated treatment with glucocorticoids. However, treatment with alfacalcidol alone failed to prevent bone loss in patients with MG receiving glucocorticoid therapy." @default.
• W2775871907 created "2018-01-05" @default.
• W2775871907 creator A5002460808 @default.
• W2775871907 creator A5007477169 @default.
• W2775871907 creator A5009884211 @default.
• W2775871907 creator A5011545641 @default.
• W2775871907 creator A5015025675 @default.
• W2775871907 creator A5021280762 @default.
• W2775871907 creator A5034938461 @default.
• W2775871907 creator A5048619957 @default.
• W2775871907 creator A5065503728 @default.
• W2775871907 creator A5065763596 @default.
• W2775871907 creator A5083691374 @default.
• W2775871907 date "2018-01-12" @default.
• W2775871907 modified "2023-10-12" @default.
• W2775871907 title "Effects of alendronate and alfacalcidol on bone in patients with myasthenia gravis initiating glucocorticoids treatment" @default.
• W2775871907 cites W1602245959 @default.
• W2775871907 cites W1897013744 @default.
• W2775871907 cites W1920107567 @default.
• W2775871907 cites W1990808425 @default.
• W2775871907 cites W1992310701 @default.
• W2775871907 cites W2026342986 @default.
• W2775871907 cites W2032314977 @default.
• W2775871907 cites W2037927763 @default.
• W2775871907 cites W2042007405 @default.
• W2775871907 cites W2042087486 @default.
• W2775871907 cites W2045080834 @default.
• W2775871907 cites W2080089180 @default.
• W2775871907 cites W2090411489 @default.
• W2775871907 cites W2093196075 @default.
• W2775871907 cites W2095741166 @default.
• W2775871907 cites W2110579859 @default.
• W2775871907 cites W2124011858 @default.
• W2775871907 cites W2126826618 @default.
• W2775871907 cites W2135241080 @default.
• W2775871907 cites W2144722417 @default.
• W2775871907 cites W2154803724 @default.
• W2775871907 cites W2157233862 @default.
• W2775871907 cites W2169198657 @default.
• W2775871907 cites W2171105433 @default.
• W2775871907 cites W2171133944 @default.
• W2775871907 cites W2191969341 @default.
• W2775871907 cites W2321227665 @default.
• W2775871907 cites W2336860975 @default.
• W2775871907 cites W2608554728 @default.
• W2775871907 cites W2612576786 @default.
• W2775871907 cites W2622196867 @default.
• W2775871907 cites W2936396720 @default.
• W2775871907 doi "https://doi.org/10.1111/cen.13537" @default.
• W2775871907 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29266368" @default.
• W2775871907 hasPublicationYear "2018" @default.
• W2775871907 type Work @default.
• W2775871907 sameAs 2775871907 @default.
• W2775871907 citedByCount "5" @default.
• W2775871907 countsByYear W27758719072019 @default.
• W2775871907 countsByYear W27758719072020 @default.
• W2775871907 countsByYear W27758719072021 @default.
• W2775871907 countsByYear W27758719072023 @default.
• W2775871907 crossrefType "journal-article" @default.
• W2775871907 hasAuthorship W2775871907A5002460808 @default.
• W2775871907 hasAuthorship W2775871907A5007477169 @default.
• W2775871907 hasAuthorship W2775871907A5009884211 @default.
• W2775871907 hasAuthorship W2775871907A5011545641 @default.
• W2775871907 hasAuthorship W2775871907A5015025675 @default.
• W2775871907 hasAuthorship W2775871907A5021280762 @default.
• W2775871907 hasAuthorship W2775871907A5034938461 @default.
• W2775871907 hasAuthorship W2775871907A5048619957 @default.
• W2775871907 hasAuthorship W2775871907A5065503728 @default.
• W2775871907 hasAuthorship W2775871907A5065763596 @default.
• W2775871907 hasAuthorship W2775871907A5083691374 @default.
• W2775871907 hasConcept C126322002 @default.
• W2775871907 hasConcept C126894567 @default.
• W2775871907 hasConcept C134018914 @default.
• W2775871907 hasConcept C141071460 @default.
• W2775871907 hasConcept C170033053 @default.
• W2775871907 hasConcept C198451711 @default.
• W2775871907 hasConcept C2775854910 @default.
• W2775871907 hasConcept C2776541429 @default.
• W2775871907 hasConcept C2776886416 @default.
• W2775871907 hasConcept C2779126354 @default.
• W2775871907 hasConcept C71924100 @default.
• W2775871907 hasConceptScore W2775871907C126322002 @default.
• W2775871907 hasConceptScore W2775871907C126894567 @default.
• W2775871907 hasConceptScore W2775871907C134018914 @default.
• W2775871907 hasConceptScore W2775871907C141071460 @default.
• W2775871907 hasConceptScore W2775871907C170033053 @default.
• W2775871907 hasConceptScore W2775871907C198451711 @default.
• W2775871907 hasConceptScore W2775871907C2775854910 @default.
• W2775871907 hasConceptScore W2775871907C2776541429 @default.
• W2775871907 hasConceptScore W2775871907C2776886416 @default.
• W2775871907 hasConceptScore W2775871907C2779126354 @default.
• W2775871907 hasConceptScore W2775871907C71924100 @default.
• W2775871907 hasFunder F4320321001 @default.
• W2775871907 hasFunder F4320321849 @default.
• W2775871907 hasIssue "3" @default.
• W2775871907 hasLocation W27758719071 @default.
• W2775871907 hasLocation W27758719072 @default.
• W2775871907 hasOpenAccess W2775871907 @default.

• next